Sugiyama Tomoyo, Kimura Shigeki, Ohtani Hirofumi, Yamakami Yosuke, Kojima Keisuke, Sagawa Yuichiro, Hishikari Keiichi, Hikita Hiroyuki, Ashikaga Takashi, Takahashi Atsushi, Isobe Mitsuaki
Cardiovascular Center, Yokosuka Kyosai Hospital, 1-16, Yonegahama-dori, Yokosuka, Kanagawa, 238-8558, Japan.
Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Cardiovasc Interv Ther. 2017 Jul;32(3):216-224. doi: 10.1007/s12928-016-0408-y. Epub 2016 Jun 23.
The progression of coronary atherosclerosis has been influenced by the presence of chronic kidney disease (CKD). This study investigated the impact of CKD stages on coronary plaque components observed on optical coherence tomography (OCT). We investigated 296 native coronary lesions with stable angina pectoris treated with stent implantation. All lesions were divided into the three groups according to the values of estimated glomerular filtration rate (eGFR, mL min 1.73 m): the non-CKD group (eGFR ≥60, n = 142), CKD group (15 ≤ eGFR < 60, n = 126), and end-stage kidney disease (ESKD) group (eGFR <15 and/or hemodialysis, n = 28). Among the groups, plaque morphologies at the narrowest culprit sites on OCT were evaluated. The CKD group had a larger lipid arc [207.5 (88.3-264.5) vs. 159.3 (73.3-227.7) degrees, P = 0.037] and longer lipid length [2.4 (0.0-5.7) vs. 0.0 (0.0-4.7) mm, P = 0.017] than the non-CKD group. The ESKD group had a thinner fibrous cap [120 (70-258) vs. 170 (100-270) μm, P = 0.044], higher prevalence of plaque rupture (28.6 vs. 12.3 %, P = 0.038), and larger calcification arc [124.8 (0.0-194.3) vs. 0.0 (0.0-125.4) degrees, P = 0.025] than the non-ESKD group (CKD + non-CKD groups). The presence of CKD was related to the growth of lipidic plaques. Furthermore, the advancement in the CKD stage to ESKD affected the occurrence of plaque rupture or progression of calcification.
慢性肾脏病(CKD)的存在会影响冠状动脉粥样硬化的进展。本研究调查了CKD分期对光学相干断层扫描(OCT)观察到的冠状动脉斑块成分的影响。我们调查了296例接受支架植入治疗的稳定性心绞痛患者的天然冠状动脉病变。根据估计肾小球滤过率(eGFR,mL·min⁻¹·1.73 m²)值将所有病变分为三组:非CKD组(eGFR≥60,n = 142)、CKD组(15≤eGFR<60,n = 126)和终末期肾病(ESKD)组(eGFR<15和/或接受血液透析,n = 28)。在各组中,评估了OCT上最狭窄罪犯部位的斑块形态。与非CKD组相比,CKD组的脂质弧更大[207.5(88.3 - 264.5)度 vs. 159.3(73.3 - 227.7)度,P = 0.037],脂质长度更长[2.4(0.0 - 5.7)mm vs. 0.0(0.0 - 4.7)mm,P = 0.017]。与非ESKD组(CKD + 非CKD组)相比,ESKD组的纤维帽更薄[120(70 - 258)μm vs. 170(100 - 270)μm,P = 0.044],斑块破裂的患病率更高(28.6% vs. 12.3%,P = 0.038),钙化弧更大[124.8(0.0 - 194.3)度 vs. 0.0(0. ---- 125.4)度,P = 0.025]。CKD的存在与脂质斑块的生长有关。此外,CKD分期进展至ESKD会影响斑块破裂的发生或钙化的进展。 (注:原文中一处“0.0(0.0 - 125.4)”括号内表述有误,推测应为“0.0(0.0 - 125.4)”,翻译时保留原文错误表述。)